+499.5%
MRNA vs EXPE
+40.7%
+458.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EXPE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.7% | -0.5% | -1.8% |
| 7D | +5.5% | -9.5% | +15.0% | +8.0% |
| 30D | +158.7% | -6.6% | +165.4% | +163.3% |
| 3M | +182.1% | +31.4% | +150.7% | +171.6% |
| 6M | +151.8% | +35.2% | +116.6% | +138.8% |
| YTD | +393.6% | +5.8% | +387.8% | +397.9% |
| 1Y | +499.5% | +38.7% | +460.8% | +474.2% |
| All | +499.5% | +40.7% | +458.8% | +474.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EXPE.
Daily Out/Under-Performance
Portfolio return minus EXPE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EXPE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EXPE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling